Overview
Recep Temel practices practicing medicine in Ege, Turkey.
Their clinical expertise encompasses Gangrene, Necrotizing Fasciitis, Exocrine Pancreatic Insufficiency, Appendix Cancer, and Splenectomy.
They are actively involved in clinical research, co-authoring 9 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Recep Temel
Is Recep Temel a top-rated expert for Gangrene?
MediFind is an objective health platform that identifies experts based on real-world data. Recep Temel is classified as an Experienced expert for Gangrene, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Recep Temel participate in research or clinical trials?
Yes. Recep Temel has published 9 articles and abstracts on conditions like Gangrene. You can view a list of Recep Temel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Appendix CancerTemel isExperienced. Learn about Appendix Cancer.
- Exocrine Pancreatic Insufficiency
- GangreneTemel isExperienced. Learn about Gangrene.
- Necrotizing FasciitisTemel isExperienced. Learn about Necrotizing Fasciitis.
- SplenectomyTemel isExperienced. Learn about Splenectomy.